saba @ neurips dec 2-6

@sabaimran_go

building - https://openpaper.ai (yc s23)

san francisco

openpaper.ai

於七月 2023 加入

809貼文 294位跟隨者 353個跟隨中

saba @ neurips dec 2-6

@sabaimran_go

年11月16日

highly considering taking the train down to san diego from san francisco for neurips

saba @ neurips dec 2-6

@sabaimran_go

年11月5日

doing a lit review is realizing that every question you have leads to 6 more papers which each lead to 6 more papers. it's academic fractals all the way down

High risk for building products that you use: overindexing on your own user profile. It is good and useful to be a consumer of what you make, but you need to disambiguate the parts of yourself that generalize to your audience.

saba @ neurips dec 2-6

@sabaimran_go

年11月4日

One of the most rewarding things about shipping consumer software is being able to tell users, 'Yeah, you can just go to the website and start using it.'

saba @ neurips dec 2-6

@sabaimran_go

年10月30日

SF has a housing shortage and that is Bad, but I wonder whether that supply constraint creates a self-selective filter that only keeps people who really want to & need to be here. That might increase the magic of the city.

saba @ neurips dec 2-6

@sabaimran_go

年10月17日

A few thoughts from building/scaling @openpaper_ai , a B2C app that helps researchers understand academic literature better. 1. Sweat the details. Go over your onboarding flow regularly, think of all the crazy ways your user might be derailed, and patch UX issues you find…

saba @ neurips dec 2-6

@sabaimran_go

年10月17日

I need you to know that my side project that turned into my main project is about to cross 100 stars and this is very exciting. Thank you for your attention to this matter.

sabaimran_go's tweet image. I need you to know that my side project that turned into my main project is about to cross 100 stars and this is very exciting.

Thank you for your attention to this matter.

saba @ neurips dec 2-6 已轉發

Arnaud Bertrand

@RnaudBertrand

年10月16日

This is actually fascinating in several respect. Pfizer's CEO says China is overtaking the U.S. in biotechnology and pharmaceuticals, and that a key reason behind this is because "we spend more time trying to think about how to slow down China rather than think how we can…

CNBC

@CNBC

年10月15日

CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation cnbc.com/2025/10/15/wel…

CNBC's tweet card. Speaking at CNBC's Invest in America Forum, the CEOs said the U.S. still leads in many sectors, but inconsistent policy and underinvestment is ceding ground.

CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation

來源: cnbc.com

saba @ neurips dec 2-6 已轉發

sandra djajic

@TakoTreba

年10月15日

Some products need VC money, deep research, heavy tech, long runway. Most don’t. You can scale far with smart distribution and a tight product. Raise only when you know where the money goes. In short, for most founders bootstrapping is best option.

saba @ neurips dec 2-6

@sabaimran_go

年10月5日

Imagine how alarmed GW would be at the current political landscape.

Steve Stewart-Williams

@SteveStuWill

年10月3日

Warning: Political Ideology May Impair Your Ability to Reason “[I]f you’re not careful, ideology won’t just shape your opinions; it’ll hijack your ability to reason altogether.” [Link below.]